Smith & Nephew CFO sells shares following interim results

5th Feb 2015 16:10

Smith and Nephew's chief financial officer sold some shares in the UK-based medical equipment maker the same day that the group posted full-year results with revenues up 6%.Julie Brown sold 11,789 shares for an individual price of 1,181p, raising a total of £139.228 in the transaction. The shares were part of an award agreement granted in March 2013.Brown, who joined the group in 2013, now holds 38,211 shares.Smith & Nephew reported on Thursday an increase in annual sales as an improved performance as a strong performance at its US hip and knee implants division offset weak results at its advanced wound management business.Chief executive Olivier Bohuon said management was "confident that the group will deliver higher underlying revenue growth and trading profit margin in 2015" after investing in the growth of Smith & Nephew's portfolio.Top Director BuysZambeef Products (ZAM) Director name: Mr John RabbAmount purchased: 4,000,000 @ 10.05p Value: £402,000Zambeef Products (ZAM) Director name: Mr Francis GroganAmount purchased: 995,000 @ 9.99p Value: £99,400Zambeef Products (ZAM) Director name: Mr Carl IrwinAmount purchased: 995,000 @ 9.99p Value: £99,400Advanced Oncotherapy (AVO) Director name: Mr Michael Bradfield Amount purchased: 1,500,000 @ 4.20p Value: £63,000Securities Trust of Scotland (STS) Director name: Mr Mark LittleAmount purchased: 10,562 @ 141.19p Value: £14,912Zambeef Products (ZAM) Director name: Mr John RabbAmount purchased: 131,187 @ 10.05p Value: £13,184Verona Pharma (VRP) Director name: Mr David EbsworthAmount purchased: 700,000 @ 1.54p Value: £10,780Top Director SellsSmith & Nephew (SN.) Director name: Ms Julie BrownAmount sold: 11,789 @ 1,181.00p Value: £139,228Nasstar (NASA) Director name: Lord Lord DaresburyAmount sold: 312,500 @ 8.00p Value: £25,000